Results for
FDA
Why Has There Been a Drop in FDA Enforcement Activity?
Reviewed by
admin
on
November 01, 2017
Rating:
5
Is The End of Animated Characters in Drug Ads Neigh?
Reviewed by
admin
on
October 09, 2017
Rating:
5
Does This Email Message from KVK Tech Violate FDA Regulations?
Reviewed by
admin
on
September 28, 2017
Rating:
5
Is FDA Most Science-Based and Less patient Centric Now that Gottlieb is in Charge?
Reviewed by
admin
on
September 27, 2017
Rating:
5
PhRMA May Be Shooting Itself in the Foot by Criticizing FDA DTC Studies
Reviewed by
admin
on
August 17, 2017
Rating:
5
Is FDA Too Slow to Approve New Drugs?
Reviewed by
admin
on
July 05, 2017
Rating:
5
Speedy Drug Approval Versus Safe Drugs: Can We Have Both?
Reviewed by
admin
on
April 19, 2017
Rating:
5
How Many Adverse Event Reports Are Submitted to the FDA? Whatever the Answer, It's at an All-Time High!
Reviewed by
admin
on
March 20, 2017
Rating:
5
Gottlieb to Head FDA: Pharma Breathes a Sigh of Relief
Reviewed by
admin
on
March 13, 2017
Rating:
5
Is "Right to Try" a Good Idea?
Reviewed by
admin
on
March 01, 2017
Rating:
5
Bob Ehrlich of DTC Perspectives Should Do Better Research & Fact Checking Before He Calls Out Media for "Misreporting" on DTC Off-Label Promotion
Reviewed by
admin
on
February 17, 2017
Rating:
5
Who Is the Most “Fantastic” Person Trump Has in Mind to Lead the FDA?
Reviewed by
admin
on
February 06, 2017
Rating:
5
Does FDA Guidance About Pharma Communications with Payors Open a Path to Off-Label Discussions?
Reviewed by
admin
on
January 18, 2017
Rating:
5
Fact Checking Puzzling Criticisms of a "Puzzling" DTC Study Proposed by FDA
Reviewed by
admin
on
January 15, 2017
Rating:
5
FDA Study is Designed to Justify a New BadAd Program for Consumers, IMHO
Reviewed by
admin
on
January 09, 2017
Rating:
5
Pharmaguy's Top Five 2017 New Year's Resolutions for the Pharma Industry
Reviewed by
admin
on
December 29, 2016
Rating:
5
FDA's Last Licks for 2016: Issues SIX (6) Enforcement Letters in December, So Far!
Reviewed by
admin
on
December 28, 2016
Rating:
5
FDA Cites TV Ads for "Compelling" "Attention-Grabbing" Distractions That Undermine Communication of Risks
Reviewed by
admin
on
December 15, 2016
Rating:
5
2016 Sees a Slight Uptick in FDA’s Enforcement Actions
Reviewed by
admin
on
December 08, 2016
Rating:
5
FDA Hears Results of Two Different Off-Label Surveys of Consumers at Recent Public Hearing
Reviewed by
admin
on
November 11, 2016
Rating:
5